SEC Filing Details
Document Details
Form
Filing Date
Jan 26, 2017
Document Date
Jan 25, 2017
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aclaris Therapeutics, Inc.
Filer
Powell Andrew Kenneth William